Clinical Trial Update: Unveiling the Germline Predisposition to Myeloproliferative Neoplasms

View source ↗

Summary

A clinical trial update from Fondazione IRCCS Policlinico San Matteo di Pavia on germline predisposition to myeloproliferative neoplasms, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloproliferative Neoplasms

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Myeloproliferative Disease, Germline Mutation | Status: RECRUITING